**Core Concept:** Low molecular weight heparin (LMWH) is a type of anticoagulant (blood thinner) that works by inhibiting the activity of Factor Xa (a key enzyme in the coagulation cascade). The cascade is a series of reactions that lead to the formation of coagulation factors and ultimately, the formation of a blood clot.

**Why the Correct Answer is Right:** LMWH specifically targets Factor Xa, a key enzyme in the coagulation cascade. By inhibiting Factor Xa, LMWH prevents the formation of thrombin, which is crucial for clot formation. The inhibition of Factor Xa also reduces the downstream activation of other coagulation factors, ultimately preventing blood clot formation and reducing the risk of thrombotic events.

**Why Each Wrong Option is Incorrect:**

A. LMWH does not primarily inhibit Factor V, which is another coagulation factor but is not the primary target for anticoagulants.
B. LMWH does not primarily inhibit Factor II (thrombin), which is also involved in clot formation but is not its primary target.
C. LMWH does not primarily inhibit Factor VII, another coagulation factor not directly involved in the primary anticoagulation mechanism of LMWH.
D. LMWH does not primarily inhibit Factor XI or XIII, which are also involved in clot formation but not its primary target.

**Clinical Pearl:** LMWH is used in clinical practice as an alternative to unfractionated heparin, with the advantage of being easier to administer and having a more predictable pharmacokinetic profile. LMWH is commonly used for thromboprophylaxis in hospitalized patients to prevent deep vein thrombosis and pulmonary embolism.

**Correct Answer:** C. LMWH primarily inhibits Factor Xa, the key enzyme in the coagulation cascade that is targeted by low molecular weight heparin to prevent clot formation.